OBM Genetics

(ISSN 2577-5790)

OBM Genetics is an international Open Access journal published quarterly online by LIDSEN Publishing Inc. It accepts papers addressing basic and medical aspects of genetics and epigenetics and also ethical, legal and social issues. Coverage includes clinical, developmental, diagnostic, evolutionary, genomic, mitochondrial, molecular, oncological, population and reproductive aspects. It publishes research articles, reviews, communications and technical notes, etc. There is no restriction on the length of the papers and we encourage scientists to publish their results in as much detail as possible.

Archiving: full-text archived in CLOCKSS.

Publication Speed (median values for papers published in 2022): Submission to First Decision: 4 weeks; Submission to Acceptance: 12 weeks; Acceptance to Publication: 13 days (1-2 days of FREE language polishing included)

Current Issue: 2023  Archive: 2022 2021 2020 2019 2018 2017

Special Issue

Application of Advanced Informatics Tools and Methods to Genetics

Submission Deadline: November 30, 2023 (Open) Submit Now

Guest Editors

Jennifer H Garvin, PhD, MBA, MA, RHIA, CPHQ, CCS, CTR FAHIMA, FAHA Division Director and Associate Professor

Health Information Management and Systems Division, School of Health and Rehabilitation Sciences, The Ohio State University, USA

Website | E-Mail

Research interests: Medical Informatics, Formative Evaluation, Implementation Science, Coded and Administrative Data

Aly Khalifa, PhD

Research Fellow at Department of Artificial Intelligence and Informatics, Mayo Clinic, Rochester, MN, USA

Website | E-Mail

Research interests: Medical Informatics; Genetics

About This Topic

The development and implementation of interoperability standards for sharing and using genetic testing data is promising. When coupled with data in clinical and public health informatics solutions genetic data has the potential to personalize treatment, focus interventions, and open new research horizons. To provide a platform for dissemination of innovative solutions that facilitate use, evaluation, and modification of standards we request submissions that describe the following studies:

  • Development, implementation, or evaluation of interoperability standards for genetic testing labs
  • Use of interoperability standards for genetic test results in Clinical Decision Support Systems, various modules of electronic health records, and health information systems.
  • Development, implementation, or evaluation of Health Level Seven International Fast Healthcare Interoperability Resources (HL7 FHIR) Clinical Genomics Implementation Guide for clinical and research purposes
  • Adaptation/customization of HL7 FHIR Clinical Genomics Implementation Guide based on using the standards in applications
  • Mapping and harmonizing HL7 FHIR ) Clinical Genomics Implementation Guide to other health related interoperability standards and common data platforms
  • Use of Artificial Intelligence (AI) and Natural Language Processing (BLP) with genetic testing data in clinical and research applications.
  • Identification, description, or evaluation of socio-technical factors or organizational attributes that promote the use of interoperability standards for genomic data, or maximize their benefits for clinical, research, and public health purposes